The clinicopathological significance and prognostic value of programmed death-ligand 1 in prostate cancer: a meta-analysis of 3133 patients

Haixiang Shen; Jin Liu; Guoliang Sun; Libin Yan; Qinchen Li; Zhize Wang; Liping Xie

doi:doi:10.18632/aging.202248

← Back

Research Paper Volume 13, Issue 2 pp 2279—2293

The clinicopathological significance and prognostic value of programmed death-ligand 1 in prostate cancer: a meta-analysis of 3133 patients

Figure 2. Forest plots HR for assessing the association between BCR-FS and PD-L1 protein expression (A) and mPD-L1 (B) in patients with prostate cancer.